Navigation Links
You had me at hello: Frisky yeast know who to 'shmoo' after 2 minutes
Date:4/18/2010

Yeast cells decide whether to have sex with each other within two minutes of meeting, according to new research published today in Nature. One of the authors of the study, from Imperial College London, says the new insights into how yeast cells decide to mate could be helpful for researchers looking at how cancer cells and stem cells develop.

Yeasts are single-celled microbes that scientists often use as model organisms, to help them understand how cells work. They usually reproduce asexually, by a process called budding, where a part of the cell is pinched off and becomes a new cell, identical to the original.

Sometimes, yeast cells reproduce sexually, by mating. The mating process involves one cell of each sex joining together, then mixing their DNA and splitting apart again. To do this, the cells each have to produce a nodule that they can join together, called a shmoo. The process of shmooing takes around two hours.

In today's new study, researchers from Imperial College London, Universit de Montral, McGill University and the University of Edinburgh determined that a yeast cell's decision to mate is controlled by a chemical change on a single protein. This change occurs two minutes after the cell detects a pheromone produced by the opposite sex, meaning that the decision to mate occurs much more quickly than scientists previously thought.

The researchers also found that in order for the mating process to be switched on, the pheromone must reach a critical concentration in the environment around the yeast cell. Below this concentration, the yeast cell continues to reproduce asexually.

"Shmooing is a very energy-intensive process for yeast cells. We think this switching process at a certain pheromone concentration may have evolved to make sure the cells only get prepared for sexual reproduction if a mate is sufficiently close enough and able to mate," said Dr Vahid Shahrezaei, one of the authors of the study from the Department of Mathematics at Imperial College London.

The researchers used a highly complex mathematical model to determine what switches the mating process on and off, factoring in experimental data about the concentration of pheromones around the cell, the concentrations of different proteins relevant to mating inside the cell and how strongly these proteins bind together.

They believe their mathematical model can potentially be used to investigate the triggers that cause changes in other cells, such as stem cells becoming heart or bone cells, or normal cells becoming cancerous. This is because mammalian cells and yeast cells contain many of the same proteins, which work together in a chain reaction to trigger a decision in the cell. Therefore, today's new model could ultimately help researchers to develop new drugs and therapies.

Dr Shahrezaei said: "Yeast cells live in a very noisy environment - they are surrounded by different chemicals, including pheromones and food, and their own machinery inside the cell produces lots of biomolecules that interact with each other. We wanted to see how cells make sense of this noisy environment and work out what is happening, at a molecular level, to make a important decision like mating.

"By combining experiments and mathematical modelling that take lots of different factors into consideration, we have been able to show exactly what is happening inside a yeast cell to make it decide whether to mate with another cell. We also showed that the mechanism that leads the cells to make their decision is very robust, meaning it is not affected by molecular noise in the environment," added Dr Shahrezaei.

"Although yeast is dramatically different from people, at a molecular and cellular level we have a lot in common," said senior author Dr Stephen Michnick, a Universit de Montral biochemistry professor and Canada Research Chair in Integrative Genomics. "The same molecules that create the switching decision in yeast are found in very similar forms in human cells. Similar switching decisions to those made by yeast are made by stem cells during embryonic development and become dysfunctional in cancers."


'/>"/>

Contact: Lucy Goodchild
lucy.goodchild@imperial.ac.uk
44-207-594-6702
Imperial College London
Source:Eurekalert

Related biology news :

1. Genetic patterns rise from huge yeast samples
2. Scientists find new genes for cancer, other diseases in plants, yeast and worms
3. Sugar-hungry yeast to boost biofuel production
4. 2010 Yeast Genetics and Molecular Biology Meeting
5. Charles Drew cancer studies with yeast yield excellent results
6. Helpful yeast battles food-contaminating aflatoxin
7. Yeast missing sex genes undergo unexpected sexual reproduction
8. Jungle yeast
9. New study reveals the protein that makes phosphate chains in yeast
10. Rhythmic genomics -- the yeast metronome and the walk of life
11. Commercial yeasts upgraded with an enzyme for biofuel production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Belgium (PRWEB) , ... February 16, 2017 , ... ... (SIOTAD) framework primarily aimed at the agricultural industry. Pilot studies are about to get ... products through IoT, Big Data and 5G innovations. The concept is expected to be ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, 2017 ... on venture growth investments in biotechnology and medical ... Richardson , M.D. to Managing Director. ... He is a board observer at InfaCare Pharmaceutical ... investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence Pharmaceuticals ...
(Date:2/16/2017)... Research and Markets has announced ... report to their offering. ... The study ... delivery plasmids, chassis organisms, synthetic cells, production systems), enabling ... bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, ...
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
Breaking Biology Technology: